The dynamic prediction tool developed based on the model had high clinical applicability, enabling the repeated measurement of perioperative CEA, CA19-9, and CA125 to be fully utilized, which will benefit the prognosis assessment and treatment management of CRC patients. Here, CEACAM5 is linked to colorectal carcinoma.